Lost in translation will address efficiently progressing innovative medicines from research into pre-clinical and first-in-man studies is important in maximising value creation in any biotech or Pharma company. That progress however must be based on robust studies to increase the probability of success. This BioWednesday event, led by tranScrip discusses how investors and entrepreneurs evaluate small companies for investment. We will give you hints and tips to take away that will help inform your critical decisions. We will explore how companies managed to navigate the hurdles towards the clinic, what made the difference, pain points, and bugbears.
View part 2 of the webinar here.